Journal Of Neuroimmune Pharmacology

The aims of the Journal of Neuroimmune Pharmacology are to promote the dissemination, interest, and exchange of new and important discoveries for the pharmacology and immunology of the nervous system. The aims parallel that of the Society on NeuroImmune Pharmacology by increasing the fundamental understanding of neurologic and neuropsychiatric disorders affected by the immune system or vice versa and towards pharmacologic measures that lead, either to a better understanding of disease mechanisms, or by improving disease outcomes. The scope of JNIP includes all primary works and reviews into the etiology, prevention, and treatment of neuroimmune and nervous system diseases affected by disordered immunity. Original studies serving to define neuroimmune modulation of environmental or endogenous cues such as toxins and drugs of abuse, hormones, and cytokines are welcome. JNIP will serve as a reliable source of interdisciplinary information bridging the fields of pharmacology, immunology, and neuroscience.

《神经免疫药理学杂志》旨在促进神经系统药理学和免疫学领域新发现和重要发现的传播、关注和交流。该杂志的目标与神经免疫药理学学会的目标相似，即通过增加对受免疫系统影响的神经和神经精神疾病（反之亦然）的根本理解，以及采取药理措施，以更好地理解疾病机制或改善疾病结果。JNIP 的范围包括所有关于受免疫紊乱影响的神经免疫和神经系统疾病的病因、预防和治疗的主要著作和评论。欢迎原创研究，以定义神经免疫调节环境或内源性线索，如毒素和滥用药物、激素和细胞因子。JNIP 将成为连接药理学、免疫学和神经科学领域的可靠跨学科信息来源。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映医学-神经科学领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为5.2，平均审稿速度为 较慢,6-12周 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。